SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-21-000051
Filing Date
2021-08-10
Accepted
2021-08-10 16:10:20
Documents
12
Period of Report
2021-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K amph-20210805x8k.htm   iXBRL 8-K 48967
  Complete submission text file 0001297184-21-000051.txt   167223

Data Files

Seq Description Document Type Size
2 EX-101.SCH amph-20210805.xsd EX-101.SCH 3212
3 EX-101.LAB amph-20210805_lab.xml EX-101.LAB 15499
4 EX-101.PRE amph-20210805_pre.xml EX-101.PRE 10523
5 EXTRACTED XBRL INSTANCE DOCUMENT amph-20210805x8k_htm.xml XML 4641
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 211159982
SIC: 2834 Pharmaceutical Preparations